Skip to content
PubMed This is a summary of 13 peer-reviewed journal articles Updated
Gastroenterology

Managing the Gut: Chronic Intestinal Pseudo-Obstruction (CIPO)

At a Glance

CAID-related chronic intestinal pseudo-obstruction management balances nutrition with relief of trapped gas and fluid. Feeding, IV nutrition (TPN), venting tubes, surgery, and motility medicines are individualized and monitored for infection, liver problems, dehydration, and heart-rhythm effects.

In CAID syndrome, the intestines do not coordinate the waves of movement needed to digest food, a condition known as Chronic Intestinal Pseudo-Obstruction (CIPO). Because the gut has severely slowed or uncoordinated motility, the goal of treatment is to provide enough calories for maintenance and growth while minimizing the painful pressure and bloating that occur when food or gas becomes trapped [1][2].

Nutritional Support: Enteral vs. Parenteral

Nutrition management should be individualized under the guidance of an intestinal-failure team. The goal is to maintain oral or enteral nutrition (feeding via a tube into the stomach or intestine) at whatever amount is safe and tolerated.

When the gut cannot safely process enough nutrition, Parenteral Nutrition (TPN) is used. This is a specialized liquid containing necessary nutrients delivered directly into the bloodstream through a central line (a catheter that terminates in a large central vein near the heart) [3].

  • Prevalence in CAID: While TPN requirements vary from patient to patient (some need partial or intermittent support), it is very common in severe cases. In one small study of eight children with the CAID SGO1 mutation, all eight required TPN at some point (median age of onset 11.8 years) [1].
  • Duration: TPN is not always permanent. Nutritional tolerance fluctuates, and in the same small cohort, at least one patient was able to stop TPN by age 18 [1]. Do not change feeding volumes or TPN rates independently; always follow your clinical team’s guidance.

The Risks of Long-Term TPN

While TPN is life-saving, it requires vigilance to manage its risks:

  1. Central Line Infections: The most serious risk is a blood infection (sepsis) related to catheter access. Fever, chills, or sudden tiredness require immediate medical evaluation [4][2].
  2. Liver Complications: Long-term TPN can cause Intestinal Failure-Associated Liver Disease (IFALD) [4][5]. To prevent this, your team will individualize your nutrition by avoiding overfeeding, cycling the nutrition (giving it over a set number of hours rather than continuously) when appropriate, balancing lipids, and maintaining safe enteral stimulation if possible [6].
  3. Rapid Electrolyte Changes: Because CAID patients often have high-volume vomiting or drainage, they can lose essential salts like potassium and sodium rapidly [7]. This can lead to dangerous heart rhythms, requiring careful tracking of fluid output.

Surgical Interventions

Surgery is individualized at an expert center and is generally reserved for when medications and TPN cannot manage severe symptoms.

  • Decompression vs Feeding Tubes: A Gastrostomy tube (G-tube / PEG) in the stomach may be used to “vent” or decompress trapped air and fluid. In contrast, a Jejunostomy tube (J-tube) is primarily used for feeding directly into the small intestine, though specialized venting procedures exist for specific cases [8][9]. Tube choice requires a motility surgeon’s assessment.
  • Ileostomy: In this procedure, the end of the small intestine is brought through the abdominal wall to a bag. While it can relieve upper pressure, it does not cure dysmotility and can lead to high-output losses, dehydration, and electrolyte imbalances. In the pediatric CAID cohort of eight children, five required an ileostomy [1].
  • Intestinal Transplant: This is considered a rare, last resort, reserved for patients who have life-threatening TPN complications, such as the loss of usable veins for IV access or severe liver failure [10][11].

Prokinetics to Support Motility

Medications like pyridostigmine or prucalopride are sometimes used to support gut motility [12]. As discussed on the heart management page, the prescribing clinician must coordinate with the cardiology team to review these medications, as some can cause clinically important bradycardia or conduction problems [1][13].

Common questions in this guide

Why might a person with CAID-related CIPO need TPN?
TPN is liquid nutrition delivered through a central line when the intestines cannot safely process or absorb enough food and fluids. It may be partial or intermittent rather than permanent, but the amount and rate should only be changed by the clinical team.
What problems need monitoring during long-term TPN?
The main concerns include bloodstream infection from the central line, liver complications, and rapid changes in potassium, sodium, and other electrolytes. Fever, chills, or sudden unusual tiredness can signal a serious line infection and need immediate medical evaluation.
How do a venting G-tube and a J-tube differ?
A G-tube placed in the stomach may be used to release trapped air and fluid, reducing pressure. A J-tube enters the small intestine and is mainly used to deliver nutrition; the right option depends on the person’s motility and surgical assessment.
Does an ileostomy cure intestinal pseudo-obstruction?
No. An ileostomy may relieve pressure in some people, but it does not fix abnormal intestinal movement and can cause high fluid losses, dehydration, and electrolyte imbalance.
When is an intestinal transplant considered in CAID?
An intestinal transplant is a rare last-resort option for life-threatening complications of long-term TPN, such as losing usable veins for IV access or developing severe liver failure. Referral decisions are made by an experienced intestinal-failure or transplant team.
Can medicines for gut motility affect the heart?
Yes. Pyridostigmine and prucalopride may be used to support motility, but some motility medicines can cause a slow heart rate or worsen conduction problems. Gastroenterology and cardiology should review the medication plan together.
What should I do if vomiting or stoma output becomes high?
High-volume vomiting or ileostomy drainage can rapidly remove fluid and salts such as sodium and potassium. Track intake, urine, and output as directed and ask the care team when IV fluids are needed; worsening weakness, dehydration, or heart symptoms require prompt medical attention.

Get notified when new evidence is published on Chronic atrial and intestinal dysrhythmia syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (13)
  1. 1

    Chronic atrial and intestinal dysrythmia syndrome: A late-onset intestinal pseudo-obstruction and cardiac dysfunction due to an SGO1 mutation.

    Adouane L, Poinsot P, Castilloux J, et al.

    JPGN reports 2025; (6(4)):327-333 doi:10.1002/jpr3.70060.

    PMID: 41245052
  2. 2

    Paediatric Intestinal Pseudo-obstruction: Evidence and Consensus-based Recommendations From an ESPGHAN-Led Expert Group.

    Thapar N, Saliakellis E, Benninga MA, et al.

    Journal of pediatric gastroenterology and nutrition 2018; (66(6)):991-1019 doi:10.1097/MPG.0000000000001982.

    PMID: 29570554
  3. 3

    Laboratory Monitoring of Children on Home Parenteral Nutrition: A Prospective Study.

    Smith A, Feuling MB, Larson-Nath C, et al.

    JPEN. Journal of parenteral and enteral nutrition 2018; (42(1)):148-155 doi:10.1177/0148607116673184.

    PMID: 29505155
  4. 4

    Intestinal failure in children receiving home parenteral nutrition: A Korean multicenter retrospective study.

    Park SW, Lee KJ, Kim L, et al.

    Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition 2026; doi:10.1002/ncp.70178.

    PMID: 42711117
  5. 5

    Intestinal Failure-Associated Liver Disease.

    Pironi L, Sasdelli AS

    Clinics in liver disease 2019; (23(2)):279-291 doi:10.1016/j.cld.2018.12.009.

    PMID: 30947877
  6. 6

    Poor Prognostic Factors in Patients with Parenteral Nutrition-Dependent Pediatric Intestinal Failure.

    Choi SJ, Lee KJ, Choi JS, et al.

    Pediatric gastroenterology, hepatology & nutrition 2016; (19(1)):44-53 doi:10.5223/pghn.2016.19.1.44.

    PMID: 27066448
  7. 7

    Metabolic complications of home parenteral nutrition and chronic intestinal failure and indications for intestinal transplantation.

    Pironi L, Joly F, Lal S, et al.

    Clinical nutrition ESPEN 2026; (75()):103416 doi:10.1016/j.clnesp.2026.103416.

    PMID: 42314930
  8. 8

    Percutaneous endoscopic gastrojejunostomy in pediatric intestinal pseudo-obstruction.

    Di Nardo G, Manca MB, Iannicelli E, et al.

    Nutrition (Burbank, Los Angeles County, Calif.) 2021; (86()):111174 doi:10.1016/j.nut.2021.111174.

    PMID: 33601120
  9. 9

    Assessment and outcome of pediatric intestinal pseudo-obstruction: A tertiary-care-center experience from Turkey.

    Çağan Appak Y, Baran M, Öztan MO, et al.

    The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology 2019; (30(4)):357-363 doi:10.5152/tjg.2019.18287.

    PMID: 30666970
  10. 10

    New Insights Into the Indications for Intestinal Transplantation: Consensus in the Year 2019.

    Kaufman SS, Avitzur Y, Beath SV, et al.

    Transplantation 2020; (104(5)):937-946 doi:10.1097/TP.0000000000003065.

    PMID: 31815899
  11. 11

    Chronic Intestinal Pseudo-obstruction.

    El-Chammas K, Sood MR

    Clinics in colon and rectal surgery 2018; (31(2)):99-107 doi:10.1055/s-0037-1609024.

    PMID: 29487492
  12. 12

    Pyridostigmine improves feeding tolerance in pediatric intestinal pseudo-obstruction: A single-center analysis.

    Capriati T, De Giorgio R, Chiusolo F, et al.

    Journal of pediatric gastroenterology and nutrition 2025; (81(4)):967-974 doi:10.1002/jpn3.70171.

    PMID: 40757431
  13. 13

    Pyridostigmine Induced Prolonged Asystole in a Patient with Myasthenia Gravis Successfully Treated with Hyoscyamine.

    Khan MS, Tiwari A, Khan Z, et al.

    Case reports in cardiology 2017; (2017()):6956298 doi:10.1155/2017/6956298.

    PMID: 28589042

This page explains nutrition support, tubes, surgery, and medicines for CAID-related CIPO for informational purposes only and does not constitute medical advice. Do not change feeding volumes, TPN rates, or medications without guidance from your gastroenterology, nutrition, cardiology, or surgical team.